HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eliseo Rondon Selected Research

afelimomab (Segard)

8/2005Afelimomab led to a modest mortality benefit in patients with severe sepsis and elevated interleukin-6 levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eliseo Rondon Research Topics

Disease

1Sepsis (Septicemia)
08/2005

Drug/Important Bio-Agent (IBA)

1afelimomab (Segard)IBA
08/2005
1Interleukin-6 (Interleukin 6)IBA
08/2005